Medicine and Dentistry
Pancreas Cancer
100%
Pancreaticoduodenectomy
58%
Surgery
53%
Pancreas Adenocarcinoma
41%
Neoplasm
31%
Systematic Review
30%
Hepatectomy
30%
Liver Transplantation
29%
Pancreas Fistula
28%
Pancreatic Surgery
25%
Meta-Analysis
25%
Cholangiocarcinoma
24%
Distal Pancreatectomy
24%
Overall Survival
19%
Gemcitabine
18%
Hepatic Arterial Infusion
18%
Learning Curve
16%
Induction Chemotherapy
15%
Odds Ratio
14%
Intraductal Papillary Mucinous Tumor
13%
Pancreas Islet Cell Tumor
12%
Treatment Effect
12%
Exome Sequencing
12%
Signal Transduction
11%
Postoperative Complication
11%
Hospital Mortality
10%
Hepatocellular Carcinoma
10%
Clinician
10%
Mucinous Cystic Neoplasm
9%
Radiation Therapy
9%
Protein P53
9%
Retrospective Cohort Study
9%
Tumor Progression
8%
Liver Tumor
8%
Body Mass Index
8%
Floxuridine
8%
Paclitaxel
8%
Fistula
7%
Long Term Survival
7%
Randomized Controlled Trial
7%
Shared Decision Making
7%
Perioperative Period
7%
Post-Hoc Analysis
7%
Precursor
7%
Retrospective Study
7%
Notch Signaling
6%
Absence
6%
Bleeding
6%
Milan Criteria
6%
Neuroendocrine Carcinoma
6%
Biochemistry, Genetics and Molecular Biology
ATRX
33%
Telomere
25%
Genetics
18%
Exome Sequencing
12%
Long Term Survival
12%
P53
11%
Chromatin Remodeling
11%
Mutated Genes
10%
Galectin-1
9%
Molecular Genetics
9%
Carcinogenesis
9%
KRAS
8%
Somatic Mutation
8%
IDH1
7%
MEN1
6%
Tumor Suppressor Gene
6%
SWI/SNF
6%
SMARCA4
6%
Prospective Cohort Study
6%
Neuroendocrine Cell
6%
Ubiquitin
6%
Ribosomal Protein
6%
Cancer Survival
6%
Morphology
6%
Precursor
6%
Lactate Dehydrogenase
6%
Ubiquitin-Conjugating Enzyme
6%
Mechanistic Target of Rapamycin
6%
Messenger RNA
6%
Tissue Regeneration
6%
Methylation
6%
mTOR Signaling
6%
Sodium Sulfate
6%
Hippo Signaling Pathway
6%
Dextran
6%
Microsatellite Instability
6%
Copy-Number Variation
5%
Gene Mutation
5%
Transcription
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
26%
Pancreas Adenocarcinoma
23%
Chemotherapy
20%
Pancreas Fistula
18%
Gemcitabine
15%
Infusion Pump
12%
Pancreas Islet Cell Tumor
12%
Bile Duct Carcinoma
12%
Neoplasm
11%
Overall Survival
9%
Floxuridine
8%
Tumor Growth
6%
Vismodegib
6%
Breast Cancer
6%
Fistula
6%
Gamma Secretase Inhibitor
6%
Experimental Animal
6%
Paclitaxel
6%
Chemoradiation Therapy
6%
Alpha Thalassemia
6%
Multiple Endocrine Neoplasia
6%
X Linked Mental Retardation
6%
Hedgehog
6%
Breast Tumor
6%
Scoliosis
6%
Cancer Growth
6%
Curcumin
6%
Postoperative Complication
6%
Nanoparticle
6%
Chemical Carcinogenesis
6%
Syndrome
6%
